Trade Gyre Therapeutics Inc - GYRE CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.0884
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.021596 %(-$4.32)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.02160%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000626 %(-$0.13)Trade size with leverage ~ $20,000.00Money from leverage ~ $19,000.00Go to platform: -0.00063%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021596 %
  (-$4.32)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000626 %
  (-$0.13)

Key Stats

• Prev. Close: 6.1358
• Open: 6.0358
• 1-Year Change: -13.61%
• Day's Range: 6.0358 - 6.2258

Trade Gyre Therapeutics Inc - GYRE

What is Gyre Therapeutics Inc (GYRE)?

Gyre Therapeutics Inc is a biotechnology company engaged in the discovery and development of therapies targeting metabolic diseases. The company focuses on modulating lipid metabolism pathways to address conditions such as non-alcoholic steatohepatitis (NASH) and other metabolic disorders. Gyre Therapeutics employs a drug discovery platform that integrates genetic and biochemical approaches to identify novel therapeutic candidates. Its research efforts aim to develop treatments that modify disease progression by targeting underlying metabolic mechanisms. The company operates within the biotechnology industry, which involves extensive research, clinical development, and regulatory compliance. Gyre Therapeutics collaborates with scientific and medical communities to advance its pipeline. Its strategic focus is on innovative therapies that address significant unmet medical needs in metabolic health.

Gyre Therapeutics Inc Stock Price Today: Live Overview

The price today is shaped by ongoing market moves, with Gyre Therapeutics Inc currently at $6.2342. Intraday, the price has spanned from $6.0358 to $6.2158, reflecting a daily percentage change of +0.3244%.

FAQ: Gyre Therapeutics Inc (GYRE)

What is the current price of GYRE stock?

Gyre Therapeutics Inc's price is currently $6.2342.

Does GYRE pay dividends?

Gyre Therapeutics Inc does not pay dividends.

Does GYRE have a formal corporate presence or regional headquarters in the UAE?

Gyre Therapeutics Inc operates in the UAE through partners and distributors and lacks an official office or subsidiary.

What is GYRE best known for?

Gyre Therapeutics Inc is most famous for its work in metabolic disease therapeutics.

What assets are typically shown together with GYRE?

Commonly shown alongside GYRE: Magic Software Enterprises Ltd, Acuity Brands Inc, Tango Therapeutics Inc